Air Liquide continues the development of its home healthcare activity in Europe with the acquisition of NordicInfu Care, a major player in home infusion therapy for patients with chronic diseases in the Nordic countries.
Founded in 2002, NordicInfu Care takes care of 4,600 patients in Sweden, Norway, Denmark and Finland. In 2012, the company generated revenue of approximately €22m (SEK 185 million).
NordicInfu Care is recognised for its expertise in the treatment of chronic diseases such as Parkinson’s disease, diabetes, and pulmonary hypertension, by subcutaneous infusion at home. Its integrated range of solutions, which includes the medication as well as the medical equipment, allows patients to be treated at home rather than go to hospital, thereby giving them greater autonomy.
Air Liquide favours continuity in the company’s management, which is presided by Mats Bergryd, relying on the expertise and the commitment of its teams. This acquisition also marks a new geographical development for Air Liquide’s home healthcare activities, which until now had little presence in these Northern European countries.
Pascal Vinet, Vice President, Healthcare Global Operations and member of the Group’s Executive Committee, commented, “We are delighted to welcome these new employees to the group. With this acquisition, Air Liquide is taking another step in home infusion treatment for patients suffering from chronic diseases in Europe. Health is one of the Group’s growth drivers.”